Clovis Oncology Inc (CLVS) is trading -8% lower at $1.535 today.

Clovis Oncology Inc has been trading between a 52-week high of $5.24 and a 52-week low of $0.581. The stock has a market cap of $221 Million.

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use.

7 Penny Stocks to Buy Before the Bull Market Returns
InvestorPlace 08-01-22

Shocking stocks: Clovis Oncology, Inc. (NASDAQ:CLVS 2.09%), Alexco Resource Corp. (AMEX:AXU -1.12%)
Stock Equity 07-26-22

Clovis Oncology to Announce Second Quarter 2022 Financial Results and Host Webcast Conference Call on August 8
Wallstreet:Online 07-20-22

Why Clovis Oncology Stock Trounced the Market Today
The Motley Fool 07-19-22

Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
InvestorPlace 07-19-22